Structural analysis of human specific cytolysin intermedilysin aiming application to cancer immunotherapy

Anticancer Research

Volumn 24, Issue 5 C, 2004, Pages 3343-3353

  Ohkura, Kazuto ^a,b   Nagamune, Hideaki ^a   Kourai, Hiroki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Cholesterol; Cytolysin; Immunotherapy; Intermedilysin

Indexed keywords

CLOSTRIDIUM PERFRINGENS TOXIN; CYTOLYSIN; INTERMEDILYSIN; PNEUMOLYSIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; CANCER IMMUNOTHERAPY; CONFERENCE PAPER; CYTOLYSIS; ERYTHROCYTE; HUMAN; HUMAN CELL; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TARGETING; STREPTOCOCCUS INTERMEDIUS; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; BACTERIAL PROTEINS; BACTERIAL TOXINS; BACTERIOCINS; CRYSTALLOGRAPHY, X-RAY; CYTOTOXINS; ERYTHROCYTE MEMBRANE; HEMOLYSIN PROTEINS; HUMANS; IMMUNOTHERAPY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT;

EID: 6344221692     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Billington SJ, Jost BH and Songer JG: Thiol-activated cytolysins: structure, function and role in pathogenesis. FEMS Microbiol Lett 182: 197-205, 2000.
2. Olofsson A, Herbert H and Thelestam M: The projection structure of perfringolysin-O (Clostridium perfringens thetatoxin). FEBS Lett 319: 125-127, 1993.
3. Korchev YE, Bashford CL, Pederzolli C, Pasternak CA, Morgan PJ, Andrew PW and Mitchell TJ: A conserved tryptophan in pneumolysin is a determinant of the characteristics of channels formed by pneumolysin in cells and planar lipid bilayers. Biochem J 329: 571-577, 1998.
4. Sekino-Suzuki N, Nakamura M, Mitsui K and O-Iwashita Y: Contribution of individual tryptophan residues to the structure and activity of θ-toxin (perfringolysin O), a cholesterol-binding cytolysin. Eur J Biochem 241: 941-947, 1996.
5. Jones S, Preiter K and Portnoy D: Conversion of an extracellular cytolysin into a phagosome-specific lysin which supports the growth of an intracellular pathogen. Mol Microbiol 21: 1219-1225, 1996.
6. Cockcroft S, Tomas GMH, Cunningham E and Ball A: Use of cytosol-dependent HL-60 cells for reconstitution studies of G-protein-regulated phosphoinositide-specific phospholipase C-β isozymes. In: Methods in Enzymology vol. 238 (Iyengar, R ed). New York, Academic Press, 1994, pp154-168.
7. Homer KA, Whiley RA and Beighton D: Proteolytic activity of oral streptococci. FEMS Microbiol Lett 67: 257-260, 1990.
8. Beighton D and Whiley RA: Sialidase activity of the "Streptococcus mitten group" and other viridans group streptococci. J Clin Microbiol 28: 1431-1433, 1990.
9. Homer KA, Denbow L, Whiley RA and Beighton D: Chondroitin sulfate depolymerase and hyalusonidase activities of viridans streptococci determined by a sensitive spectrophotometric assay. J Clin Microbiol 31: 1648-1651, 1993.
10. Homer KA, Whiley RA and Beighton D: Production of specific glycosidase activities by Streptococcus intermedius starin UNS35 grown in the presence of mucin. J Med Microbiol 41: 184-190, 1994.
11. Nagamune H, Ohnishi C, Katsuura A, Fushitani K, Whiley RA, Tsuji A and Matsuda Y: Intermedilysin, a novel cytotoxin specific for human cells, secreted by Streptococcus Intermedius UNS46 isolated from a human liver abscess. Infect Immun 64: 3093-3100, 1996.
12. Nagamune H, Ohnishi C, Katsuura A, Taoka Y, Fushitani K, Whiley RA, Yamashita K, Tsuji A, Matsuda Y, Maeda T, Kourai H and Kitamura S: Intermedilysin: a cytolytic toxin specific for human cells of a Streptococcus intermedius isolated from human liver abscess. In: Streptococci and the Host (Horaud T, Bouvet A, Leclercq R, de Montclos H, Sieard M eds). New York, Plenum Press, 1997, pp773-775.
13. Nagamune H: Streptococcal cytolysins. Seikagaku 69: 343-348, 1997.
14. Nagamune H, Whiley RA, Goto T, Inai Y, Maeda T, Hardie JM and Kourai H: Distribution of the intermedilysin gene among the Anginosus group streptococci and correlation between intermedilysin production and deep-seated infection with Streptococcus intermedius. J Clin Microbiol 38: 220-226, 2000.
15. Funk PG, Staats JJ, Howe M, Nagaraja TG and Chengappa MM: Identification and partial characterization of an Actinomyces pyogenes hemolysin. Vet Microbiol 50: 129-142, 1996.
16. Billington SJ, Jost BH, Cuevas WA and Bright KR: The Arcanobacterium (Actinomyces) pyogenes hemolysin, pyolysin, is a novel member of the thiol-activated cytolysin family. J Bacteriol 779: 6100-6106, 1997.
17. Rossjohn J, Feil SC, McKinstry WJ, Tweten RK and Parker MW: Structure of a cholesterol-binding thiol-activated cytolysin and a model of its membrane form. Cell 89: 685-692, 1997.
18. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F and Higgins DG: The ClustalX windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucl Acid Res 24: 4876-4882, 1997.
19. Laskowski RA, MacArthur MW, Moss DS and Thornton JM: PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 26: 283-291, 1993.
20. Brunger AT, Kuriyan J and Karplus M: Crystallographic R factor refinement by molecular dynamics. Science 235: 458-460, 1987.
21. Gasteiger J and Marsili M: Interative partial equalization of orbital electronegativity-A rapid access to atomic charges. Tetrahedron 36: 3219-3228, 1980.
22. Minor W: "XDISPLAYF Program", Purdue Univ., West Lafayette, IN, USA 1993.
23. Otwinowski Z: Oscillation data reduction program. In: Proceedings of the CCP4 Study Weekend 29-30 January, Warrington, pp56-62, 1993.
24. Matthews BW: Solvent content of protein crystals. J Mol Biol 33: 491-497, 1968.